SLAMF1 and breast carcinoma: Related to breast cancer, the engineered rMV-SLAMblind vector carrying the signaling lymphocyte activation molecule (SLAM) targeting the poliovirus receptor-related 4 (PVRL4), showed antitumor activity against mice implanted with human breast cancer xenografts [50].